Apr 1, 2024 | Benefits preservation, Comparative Effectiveness, Cost Savings, Drug costs, MedBen Rx, Pharmacies, Pharmacy Benefits Manager (PBM), Rx Costs, Savings, Specialty Drugs, Transparency
Employers are turning away from the “big three” pharmacy benefits managers to other PBMs that offer greater transparency and lower costs, says Wharton professor of health care management Lawton Robert Burns. As one of those alternatives, MedBen Rx is...
Mar 5, 2024 | Appropriateness Solutions, Comparative Effectiveness, Cost Savings, Drug costs, MedBen Rx, Rx Costs, Value
At January’s Benefits Advisory Conference, MedBen President & CEO Kurt Harden observed that when the Food and Drug Administration (FDA) evaluates a new drug to be approved for sale, it has to be safe and effective, but not necessarily superior to...
Jan 5, 2024 | Access solutions, Acquisition Cost Index (ACI), Appropriateness Solutions, Benefits preservation, Comparative Effectiveness, Drug costs, MedBen Rx, Pricing solutions, Specialty Drugs
Pfizer, Sanofi, Takeda Pharmaceutical, and other drugmakers will raise the prices of more than 500 drugs in early January, according to an analysis by health care researchers 3 Axis Advisors. Inflation and rising manufacturing costs will contribute to the price...
Oct 30, 2023 | Appropriateness Solutions, Comparative Effectiveness, Drug costs, MedBen Rx, Pharmacies, Prescription drugs, Research
MedBen Rx’s expanded pharmacy solutions offer a variety of ways to reduce your prescription drug spend… including appropriateness solutions that use clinical-based research to recommend the most effective drugs to your plan members. Comparative...
Feb 21, 2023 | Comparative Effectiveness, MedBen Rx, Research, Rx Advertising, Rx Costs, Rx prices, Rx Spending, TruDataRx
Drug companies spend $6 billion per year on direct-to-consumer ads with the goal of getting patients to ask their doctors to prescribe drugs that, in many instances, cost substantially more but are less effective than their current medications. And with no comparative...
Jan 6, 2023 | Comparative Effectiveness, Cost Plus Pricing, MedBen Rx, News, Prescription drugs, Rx Costs, Rx prices, Specialty Drugs
From Reuters: “Drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA plan to raise prices in the United States on more than 350 unique drugs in early January, according to data analyzed by healthcare research...
